Refresh

MAVENS BIOTECH LTD. - Statement of deviation or variation


15 Apr 2016
Mavens Biotech Ltd has submitted to BSE a copy of the statement of deviation or variation in public issue, right issue, preferential issue etc. for the quarter ended March 31, 2016.

Source: BSE India

View all announcements for MAVENS BIOTECH LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com